SE9903031D0 - Peptide mixture and vaccine against a chronic viral infection - Google Patents

Peptide mixture and vaccine against a chronic viral infection

Info

Publication number
SE9903031D0
SE9903031D0 SE9903031A SE9903031A SE9903031D0 SE 9903031 D0 SE9903031 D0 SE 9903031D0 SE 9903031 A SE9903031 A SE 9903031A SE 9903031 A SE9903031 A SE 9903031A SE 9903031 D0 SE9903031 D0 SE 9903031D0
Authority
SE
Sweden
Prior art keywords
hepatitis
peptide mixture
viral infection
vaccine against
mixture
Prior art date
Application number
SE9903031A
Other languages
English (en)
Inventor
Catharina Hultgren
Matti Saellberg
Original Assignee
Eurodiagnostica Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurodiagnostica Ab filed Critical Eurodiagnostica Ab
Priority to SE9903031A priority Critical patent/SE9903031D0/sv
Publication of SE9903031D0 publication Critical patent/SE9903031D0/sv
Priority to PCT/EP2000/008124 priority patent/WO2001016163A2/en
Priority to EP00969241A priority patent/EP1206278A2/en
Priority to JP2001519724A priority patent/JP2003508409A/ja
Priority to AU79031/00A priority patent/AU7903100A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE9903031A 1999-08-27 1999-08-27 Peptide mixture and vaccine against a chronic viral infection SE9903031D0 (sv)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE9903031A SE9903031D0 (sv) 1999-08-27 1999-08-27 Peptide mixture and vaccine against a chronic viral infection
PCT/EP2000/008124 WO2001016163A2 (en) 1999-08-27 2000-08-21 Peptide mixture and vaccine against a chronic viral infection
EP00969241A EP1206278A2 (en) 1999-08-27 2000-08-21 Peptide mixture and vaccine against a chronic viral infection
JP2001519724A JP2003508409A (ja) 1999-08-27 2000-08-21 慢性ウイルス感染に対するペプチド混合物及びワクチン
AU79031/00A AU7903100A (en) 1999-08-27 2000-08-21 Peptide mixture and vaccine against a chronic viral infection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9903031A SE9903031D0 (sv) 1999-08-27 1999-08-27 Peptide mixture and vaccine against a chronic viral infection

Publications (1)

Publication Number Publication Date
SE9903031D0 true SE9903031D0 (sv) 1999-08-27

Family

ID=20416772

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9903031A SE9903031D0 (sv) 1999-08-27 1999-08-27 Peptide mixture and vaccine against a chronic viral infection

Country Status (5)

Country Link
EP (1) EP1206278A2 (sv)
JP (1) JP2003508409A (sv)
AU (1) AU7903100A (sv)
SE (1) SE9903031D0 (sv)
WO (1) WO2001016163A2 (sv)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2824326B1 (fr) * 2001-05-04 2004-03-19 Commissariat Energie Atomique Melange de peptides issus des proteines e6 et/ou e7 de papillomavirus et leurs applications
US7351413B2 (en) 2002-02-21 2008-04-01 Lorantis, Limited Stabilized HBc chimer particles as immunogens for chronic hepatitis
BRPI0411127A (pt) * 2003-06-10 2006-05-23 Univ Melbourne composição de matéria para modulação de resposta imuno num sujeito a um antìgeno alvo e respectivos método de modulação, processo de produção de células de apresentação de antìgeno e método de tratamento e/ou profilaxia de doença ou condição associada à presença de antìgeno alvo de interesse
GB0608368D0 (en) * 2006-04-28 2006-06-07 Isis Innovation Process for making Oligopeptides
EP2402023A1 (en) * 2006-06-28 2012-01-04 Statens Serum Institut Expanding the t cell repertoire to include subdominant epitopes by vaccination with antigens delivered as protein fragments or peptide cocktails
US8080645B2 (en) 2007-10-01 2011-12-20 Longhorn Vaccines & Diagnostics Llc Biological specimen collection/transport compositions and methods
US8097419B2 (en) 2006-09-12 2012-01-17 Longhorn Vaccines & Diagnostics Llc Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009
US9481912B2 (en) 2006-09-12 2016-11-01 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
US11041215B2 (en) 2007-08-24 2021-06-22 Longhorn Vaccines And Diagnostics, Llc PCR ready compositions and methods for detecting and identifying nucleic acid sequences
AU2008293504B2 (en) 2007-08-27 2012-04-12 Longhorn Vaccines & Diagnostics, Llc Immunogenic compositions and methods
US10004799B2 (en) 2007-08-27 2018-06-26 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
EP2106803A1 (en) 2008-04-04 2009-10-07 Fondazione Centro San Raffaele del Monte Tabor Method to design and uses of overlapping peptides for monitoring T-cell responses in HIV patients
CN102060929A (zh) * 2010-06-07 2011-05-18 夏书奇 T细胞免疫平衡肽
WO2015089469A1 (en) * 2013-12-13 2015-06-18 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Multi-epitope tarp peptide vaccine and uses thereof
US20220257748A1 (en) * 2019-06-07 2022-08-18 Oregon Health & Science University Hepatitis b virus-specific t cell responses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9201139D0 (en) * 1992-01-20 1992-03-11 Connaught Lab Synthetic peptides for a rubella vaccine
NZ299048A (en) * 1992-03-06 1998-09-24 Innogenetics Sa Nv Modified peptides corresponding to immunologically useful epitopes in hiv, hcv and htlv and their use especially when biotinylated
WO1996022067A2 (en) * 1994-12-27 1996-07-25 United Biomedical, Inc. Peptide ratchet libraries for ctl-inducing vaccines and therapeutics

Also Published As

Publication number Publication date
EP1206278A2 (en) 2002-05-22
WO2001016163A3 (en) 2001-09-07
WO2001016163A2 (en) 2001-03-08
JP2003508409A (ja) 2003-03-04
AU7903100A (en) 2001-03-26

Similar Documents

Publication Publication Date Title
SE9903031D0 (sv) Peptide mixture and vaccine against a chronic viral infection
AU771827B2 (en) HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV
Wiktor et al. Antigenic properties of rabies virus components
DK11789A (da) Rekombinante vaccinia-vira
DK0596979T3 (da) Rekombinante nucleinsyrer fra plantevirus
ES2075440T3 (es) Vacuna contra la hepatitis b.
AU2007202739A1 (en) HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV
NO167359C (no) Fremgangsmaate for fremstilling av en vaksine mot infeksjon av hepatitis b virus.
RU2319505C2 (ru) Очищенные оболочечные белки вируса гепатита с для диагностического и терапевтического применения
ATE134195T1 (de) Peptidfragmente von hiv
SE9202968D0 (sv) New peptides, diagnostic antigens, use thereof, vaccines and medicaments
AR009365A1 (es) Vacunas del virus de la fiebre aftosa (fmdv), peptidos, secuencias de adn y el uso de los peptidos en sistemas de deteccion y el uso de la vacuna fmdc para la preparacion de una composicion para inmunizar cerdos y ganado vacuno
EP0236977A3 (en) Bovine virus diarrhea and hog cholera vaccines
KR950005326A (ko) 재조합 아데노바이러스 백신
Beauverger et al. Serotype-specific and canine distemper virus cross-reactive H-2Kk-restricted cytotoxic T lymphocyte epitopes in the measles virus nucleoprotein
EP0257721B1 (en) Vaccine
WO2007127290A3 (en) Method for producing viral vaccine and therapeutic peptide antigens
GB9925966D0 (en) Threapeutic vaccines against variable viruses and other targets
TR200202169T1 (tr) Tanı ve tedavide kullanım için pürifiye hepatit C virüsü zarf proteinleri.
AU6839598A (en) Antigenic structural peptide, antigenic and immunogenic compounds and uses for detecting, preventing and treating an hcv infection
ES2163405T3 (es) Virus recombinantes que comprenden sitios de escision proteoliticos artificiales.
RU94030478A (ru) Рекомбинантный вирус, способ его получения, способ иммунизации, способ получения протеина, вакцинная композиция, применение рекомбинантного вируса
AU2004200155C1 (en) HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV
TH4070EX (th) ลำดับ dna ที่มีรหัสของเซอร์เฟสแอนติเจนโปรตีน p31 ที่ดัดแปลงของไวรัสเฮพพาทิทิส บี
AU2006235980B9 (en) HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV